Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sangani HospitalsNSE:SANGANI -2.30%81 ROE % is 18.26% as of Mar. 2026, which is 47% above its 10-year median of 12.44. GuruFocus rates NSE:SANGANI with a GF Score™ of 81/100 and a GF Value™ of ₹303.41 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 637 Healthcare Providers & Services companies, Sangani Hospitals ranks better than 71.59% on this metric.
The historical rank and industry rank for Sangani Hospitals's ROE % or its related term are showing as below:
NSE:SANGANI'
s ROE % Range Over the Past 10 Years
Min: 7.45 Med: 12.44 Max: 44.84
Current: 13.15
During the past 7 years, Sangani Hospitals's highest ROE % was 44.84%. The lowest was 7.45%. And the median was 12.44%.
NSE:SANGANI's ROE % is ranked better than 71.59% of 637
companies
in the Healthcare Providers & Services industry
Industry Median: 5.87
vs NSE:SANGANI: 13.15
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Sangani Hospitals ROE % Related Terms
Sangani Hospitals ROE % Historical Data
* Premium members only.
The historical data trend for Sangani Hospitals's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Sangani Hospitals's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sangani Hospitals ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sangani Hospitals's ROE % distribution charts can be found below:
* The bar in red indicates where Sangani Hospitals's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Sangani Hospitals (NSE:SANGANI) has a ROE % of 18.26% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sangani Hospitals and its competitors. This is 47% above median its historical median of 12.44. Over the past decade, Sangani Hospitals' ROE % has ranged from 7.45 to 44.84. According to the industry distribution chart, Sangani Hospitals ranks #181 out of 637 companies in the Healthcare Providers & Services industry, placing it in the top 28.4%.
Is Sangani Hospitals' ROE % too high?
Sangani Hospitals' current ROE % of 18.26% is 47% above median its 10-year median of 12.44. Over the past 10 years, this metric has ranged from a low of 7.45 to a high of 44.84. The Healthcare Providers & Services industry median ROE % is 5.87. Sangani Hospitals' value of 18.26% is 211.1% above this industry median. Based on the distribution chart, Sangani Hospitals ranks #181 out of 637 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sangani Hospitals has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sangani Hospitals' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sangani Hospitals ranks #181 out of 637 companies for ROE %. This puts Sangani Hospitals in the upper half of its industry. The industry median ROE % is 5.87. Sangani Hospitals' value of 18.26% is 211.1% above this benchmark. Historically, Sangani Hospitals' own ROE % has ranged from 7.45 to 44.84 over the past decade. While the company's 10-year median is 12.44 vs. the industry median of 5.87, Sangani Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.87, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sangani Hospitals's current ROE % of 18.26% is 211.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sangani Hospitals and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sangani Hospitals's current ROE % is 18.26%, which is 47% above median its own 10-year median of 12.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangani Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Sangani Hospitals (NSE:SANGANI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹303.41, compared to a current price of ₹48.75 — trading 83.9% below its estimated fair value. The current ROE % is 18.26%, which is 47% above median its 10-year median of 12.44 and 211.1% above the Healthcare Providers & Services industry median of 5.87. Sangani Hospitals' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Sangani Hospitals (NSE:SANGANI), the current ROE % is 18.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sangani Hospitals (NSE:SANGANI) Overvalued in 2026?
Based on GuruFocus' analysis, Sangani Hospitals stock appears to be undervalued.
The current stock price of ₹48.75 is trading 83.9% below its estimated GF Value™ of ₹303.41.
GuruFocus considers Sangani Hospitals to be Possible Value Trap.
Key valuation signals for NSE:SANGANI:
ROE %: 18.26% (47% above median its 10-year median of 12.44)
GF Value™: ₹303.41 vs. price of ₹48.75 (83.9% below fair value)
Industry Position: 211.1% above the Healthcare Providers & Services median (#181 of 637)
No single metric tells the full story. See the NSE:SANGANI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sangani Hospitals Ltd is a multi-specialty healthcare provider operating in the Keshod and Veraval regions of Gujarat. Its services predominantly include super specialty services, specialty services, and other support services. It also operates a pathology laboratory and medical store. Currently, it operates out of two hospitals i.e. Sangani Hospital at Keshod, Junagadh, Gujarat and Sangani Super Speciality Hospital, Veraval, Gujarat. The company operates in a single segment, which is Healthcare. The company operates departments and units, including General Medicine, ENT, Dialysis, Orthopedics, General Surgery, Urosurgery, Trauma, and Physiotherapy.
81GF Score
Get the complete analysis for NSE:SANGANI
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANGANI has been successfully added to your 
